Hosted on MSN
ResMed shares charge higher on strong Q1 update
ResMed Inc (ASX: RMD) shares are ending the week on a positive note. At the time of writing, the sleep disorder treatment company's shares are up 2.5% to $39.90. This follows the release of the ...
ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...
ResMed (NYSE:RMD) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below illustrates ...
Web Manuals has announced a new onboarding package that is designed to support the confident adoption of Amelia Co-Author, the company’s AI-powered editing tool for aviation documentation. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback